The US Eclipta Prostrata (False Daisy) Extract Market is gaining traction as demand increases for natural botanical ingredients across wellness, nutritional supplements, herbal remedies, and cosmetic formulations. The United States represents a key market within the global industry, supported by evolving consumer preferences, growing interest in herbal products, and increasing adoption of plant-based ingredients in modern health and personal care applications. 

The global Eclipta Prostrata (False Daisy) Extract Market is gaining momentum as consumers and manufacturers increasingly turn toward plant-based ingredients for wellness, personal care, and traditional health applications. Eclipta prostrata, commonly known as False Daisy, is valued for its use in herbal formulations and its potential applications across medicine, nutritional supplements, and cosmetics. According to The Insight Partners, the market was valued at US$ 153.83 million in 2025 and is projected to reach US$ 271.22 million by 2034, expanding at a CAGR of 6.50% from 2026 to 2034.

The growing preference for botanical extracts is creating favorable conditions for Eclipta Prostrata extract manufacturers, suppliers, and product developers. The market is analyzed by extraction type, including 10:1 and 20:1, and by application across medicine, nutritional supplements, and cosmetics. The increasing adoption of natural ingredients, expanding interest in herbal remedies, and growing demand for botanical-based personal care products are among the major factors supporting market development through 2034.

Download Sample Report  https://www.theinsightpartners.com/sample/TIPRE00014658

Key Market Drivers

Growing Demand for Natural and Herbal Ingredients

One of the strongest drivers for the Eclipta Prostrata (False Daisy) Extract Market is the broader shift toward natural and plant-derived ingredients. Consumers are becoming more interested in products perceived as botanical, clean-label, and naturally sourced. This trend is encouraging manufacturers of wellness products, supplements, and personal care formulations to explore herbal extracts that can provide functional value while supporting natural-product positioning.

Eclipta prostrata has a long history of use in traditional herbal practices, which provides an established foundation for its incorporation into modern formulations. As manufacturers seek botanical ingredients that align with evolving consumer preferences, False Daisy extract is gaining attention as a versatile plant-based ingredient.

Rising Interest in Herbal Remedies and Wellness Products

The growing wellness economy is another important growth catalyst. Consumers are increasingly incorporating nutritional supplements and herbal products into everyday health and wellness routines. This has created opportunities for botanical extracts to move beyond traditional applications and become components of modern formulations.

False Daisy extract can be positioned across several product categories, including nutritional supplements and herbal preparations. The Insight Partners identifies the rising use of False Daisy extract in health products and its role in modern remedies as important growth drivers for the industry.

Expanding Applications in Cosmetics and Skincare

The cosmetics segment represents another significant opportunity for Eclipta Prostrata extract suppliers. Demand for botanical skincare is increasing as consumers seek formulations containing recognizable plant-derived ingredients. Natural and herbal positioning has become an important product differentiation strategy for beauty and personal care brands.

The growing demand for natural skincare products is expected to encourage greater incorporation of botanical extracts into creams, serums, haircare products, and other personal care formulations. This creates opportunities for extract producers to develop standardized ingredients designed for specific cosmetic applications.

Advancements in Extraction and Product Standardization

Technological improvements in botanical extraction are also supporting market development. Manufacturers are focusing on extraction efficiency, consistency, purity, and standardized concentrations to meet the requirements of commercial formulations. The availability of different extraction ratios, including 10:1 and 20:1, enables manufacturers to select ingredients according to formulation requirements.

Improved processing and quality-control practices can help suppliers deliver more consistent botanical extracts while supporting broader adoption by supplement, cosmetic, and pharmaceutical manufacturers. As product developers place greater emphasis on ingredient traceability and quality, standardized extraction processes are likely to become increasingly important.

Market Trends and Opportunities

Sustainability is emerging as an important consideration across the botanical ingredients industry. Increasing awareness of sustainable sourcing is encouraging companies to examine cultivation, harvesting, processing, and supply-chain practices. For Eclipta Prostrata extract producers, responsible sourcing can strengthen product positioning while addressing growing expectations from environmentally conscious consumers and brands.

Another important opportunity lies in the convergence of traditional herbal knowledge with modern product development. Companies can explore innovative formulations that incorporate False Daisy extract into contemporary wellness, skincare, and nutritional products. This trend may help expand the ingredient's addressable market and introduce it to new consumer groups.

The market also offers opportunities for manufacturers to develop application-specific extracts with improved consistency and formulation compatibility. Research into extraction methods, ingredient combinations, and product performance could further support commercialization.

Segmentation Overview

Based on type, the Eclipta Prostrata (False Daisy) Extract Market is segmented into 10:1 extraction and 20:1 extraction. By application, the market covers medicine, nutritional supplements, and cosmetics. This segmentation highlights the ingredient's diverse commercial potential and provides opportunities for companies to target specialized end-use categories.

Geographically, the report evaluates the market across North America, Europe, Asia Pacific, South and Central America, and the Middle East and Africa, providing a comprehensive view of regional demand, competitive conditions, and emerging opportunities.

Top Players in the Eclipta Prostrata Extract Market

The competitive landscape includes several companies participating in the development and supply of Eclipta Prostrata extract. Key players profiled by The Insight Partners include Ambe NS Agro Products, Amruta Herbals, Campo Research, Dermalab, Haldin, Phyto Life Sciences, and The Garden of Naturalsolution.

Competition is expected to increasingly center on extract quality, product consistency, sourcing practices, formulation support, application expertise, and the ability to address evolving customer requirements.

Future Outlook

The Eclipta Prostrata (False Daisy) Extract Market is positioned for sustained expansion through 2034, supported by the continued shift toward botanical ingredients, increasing interest in herbal wellness, expanding natural skincare demand, and greater attention to sustainable sourcing. The market's projected increase from US$ 153.83 million in 2025 to US$ 271.22 million by 2034 indicates significant commercial potential for ingredient manufacturers and downstream product developers.

Going forward, innovation in extraction technology, quality standardization, sustainable supply chains, and application-specific formulations is likely to shape competitive strategies. Companies that successfully combine botanical expertise with modern formulation capabilities can benefit from the expanding demand for natural health, wellness, and cosmetic ingredients.